5α-cholestan-3β-ol - ≥98% , CAS No.80-97-7

CAS: 80-97-7 Cat. No.: C130209 Summenformel: C27H48O Molekulargewicht: 388.669 Beilstein Registry Number: 2418594 EG-Nummer: 201-315-8
Zu bestellen verfügbar
QUALITÄT & REINHEIT ≥98%
Synonyms
5a-Dihydrocholesterol|3beta-Hydroxy-5alpha-cholestane|Dihydrocholesterol|3b-Hydroxy-5a-cholestane|Cholestan-3-ol, (3.beta.)- #|(+)-Dihydrocholesterol|A-ol|CHOLESTANOL [USP-RS]|CHOLESTAN-3-OL,(3.BETA.,5.ALPHA.)-|(3b,5a)-Cholestan-3-ol|Dihydrocholesterol;5-Cholestanol;NSC 18188|5-Cholestan-3-ol|Cholestane, 3beta-hydroxy-, 5alpha-|Zymostanol|A-Cholestan-3|5a-Cholestan-3b-ol|5alpha-Cholestanol|3beta-Hydroxycholestane|5-alpha-Cholestan-3-beta-ol|5alpha-Cholestan-3beta-ol|beta-Cholestanol|Cholestan-3-ol, (3b,5a)-|(3S,5S,8R,9S,10S,13R,14S,17R)-17-((R)-1,5-dimethylhexyl)-10,13-dimethylhexadecahydrocyclopenta[a]phenanthren-3-ol|Cholestan-3b-ol|(3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol|(5alpha)-cholestan-3beta-ol|Cholestan-3-ol, (3.beta.,5.alpha.)-|CHOLESTANOL|DIHYDROCHOLESTEROL [INCI]|(3beta,5alpha)-cholestan-3-ol|3b-Hydroxycholestane|5a-Cholestanol|Cholestan-3beta-ol|Cholestanol (VAN)|5 alpha -Cholestan-3 beta -ol|Cholestan-3-ol, (3beta,5alpha)-|5alpha-Dihydrocholesterol
Storage
Store at 2-8°C
Shipped In
Wet ice
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1g
C130209-1g
—
4 Auf Lager
27,68€
5g
C130209-5g
—
5 Auf Lager
83,22€
25g
C130209-25g
—
2 Auf Lager
312,30€
Enter a quantity for the sizes you want to add.

Übersicht

It was used as a standard in lipid analysis using HPLC.

Spezifikationen

Synonyme
5a-Dihydrocholesterol | 3beta-Hydroxy-5alpha-cholestane | Dihydrocholesterol | 3b-Hydroxy-5a-cholestane | Cholestan-3-ol, (3.beta.)- # | (+)-Dihydrocholesterol | A-ol | CHOLESTANOL [USP-RS] | CHOLESTAN-3-OL,(3.BETA.,5.ALPHA.)- | (3b,5a)-Cholestan-3-ol | Dihydrocholesterol;5-Cholestanol;NSC 18188 | 5-Cholestan-3-ol | Cholestane, 3beta-hydr Show more
Spezifikationen & Reinheit
≥98%
Biochemische und physiologische Mechanismen
It is derived from cholesterol by the action of intestinal microorganisms.It is known to induce the formation of gall stones in rabbits in the presence of sodium ions.
Storage
Store at 2-8°C
Verschickt in
Wet ice
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Reinheit
≥98%
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488180124
SMILES
CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C
IUPAC Name
(3S,5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKey
QYIXCDOBOSTCEI-QCYZZNICSA-N
InChI
1S/C27H48O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-25,28H,6-17H2,1-5H3/t19-,20+,21+,22+,23-,24+,25+,26+,27-/m1/s1
Isomere SMILES
C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C
WGK Deutschland
3
Molekulargewicht
388.669
Beilstein
2418594
Reaxys
1914455
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1914455&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
KlasseSteroids and steroid derivatives
SubclassCholestane steroids
Intermediate Tree Nodes Not available
Direct ParentCholesterols and derivatives
Alternative Parents 3-beta-hydroxysteroids  Secondary alcohols  Cyclic alcohols and derivatives  Hydrocarbon derivatives  
Molecular FrameworkAliphatic homopolycyclic compounds
Substituents Cholesterol-skeleton - Cholesterol - 3-beta-hydroxysteroid - Hydroxysteroid - 3-hydroxysteroid - Cyclic alcohol - Secondary alcohol - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Alcohol - Aliphatic homopolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as cholesterols and derivatives. These are compounds containing a 3-hydroxylated cholestane core.
External Descriptors Cholesterol and derivatives
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
POLA1 Tclin DNA polymerase alpha subunit (225 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
POLB Tchem DNA polymerase beta (23632 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
Top2 DNA topoisomerase II (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus fumigatus (16427 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

16 results found

Lot NumberCertificate TypeDatumArtikel
F2208245F2208245Certificate of AnalysisDec 12, 2025 C130209
F2208246F2208246Certificate of AnalysisDec 12, 2025 C130209
A2409214A2409214Certificate of AnalysisOct 13, 2025 C130209
A2409215A2409215Certificate of AnalysisOct 13, 2025 C130209
A2409216A2409216Certificate of AnalysisOct 13, 2025 C130209
A2409224A2409224Certificate of AnalysisOct 13, 2025 C130209
B2226480B2226480Certificate of AnalysisSep 09, 2025 C130209
B2226485B2226485Certificate of AnalysisSep 09, 2025 C130209
B2226458B2226458Certificate of AnalysisSep 09, 2025 C130209
I2321094I2321094Certificate of AnalysisJul 10, 2025 C130209
I2321116I2321116Certificate of AnalysisJul 10, 2025 C130209
J2126710J2126710Certificate of AnalysisMay 09, 2025 C130209
F2309557F2309557Certificate of AnalysisMar 04, 2025 C130209
F2309558F2309558Certificate of AnalysisMar 04, 2025 C130209
F2309559F2309559Certificate of AnalysisMar 04, 2025 C130209
F2310090F2310090Certificate of AnalysisMar 04, 2025 C130209
Chemische und physikalische Eigenschaften
LöslichkeitInsoluble in water.
Gefrierpunkt (°C)24° (C=1,Dioxane)
Schmelzpunkt (°C)140 °C
Molekulargewicht388.7
XLogP39.400
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count1
Rotatable Bond Count5
Exact Mass388.371 Da
Monoisotopic Mass388.371 Da
Topological Polar Surface Area20.200 Ų
Heavy Atom Count28
Formal Charge0
Complexity540.000
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicherheit und Gefahren (GHS)
WGK Deutschland
3
Reaxys
1914455
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1914455&ln=
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

Item-specific, validated protocols are not provided for this listing. Below are general, literature-informed procedures suitable for research use. Adjust to your system and consult the CoA/SDS.

A. Preparation of stock solutions (analytical/lipid work)

  • Weigh in a dry vessel. Add ethanol or CHCl3:MeOH (2:1) to 1–10 mg/mL. Warm to 40–50 °C with brief sonication to fully dissolve. Store aliquots at 2–8 °C tightly sealed; equilibrate to RT before opening to prevent moisture ingress.

B. Thin-film hydration for liposome incorporation

  • Dissolve phospholipids and 5α-cholestan-3β-ol in CHCl3:MeOH (2:1) at desired molar ratio (e.g., 20–40 mol% sterol). Evaporate under reduced pressure to a thin film. Dry under high vacuum ≥2 h. Hydrate with warm buffer (e.g., HEPES 10 mM, NaCl 150 mM, pH 7.4) with vigorous vortexing. Size by extrusion if needed.

C. Silylation for GC analysis

  • To 0.5–1 mg sample, add 100–200 µL BSTFA + 1% TMCS in acetonitrile. Heat 60–70 °C for 30 min. Inject derivatized sample directly for GC-FID/MS.

D. Esterification (preparative)

  • Dissolve sterol in dry DCM. Add DMAP (5 mol%) and acyl chloride (1.2 eq) dropwise at 0 °C in presence of DIPEA (2 eq). Stir at RT 2–4 h. Wash with NaHCO3, water, brine, dry, and purify by silica gel.
Biological Roles

General biochemistry (literature; not a medical claim)

  • Endogenous occurrence: 5α-cholestan-3β-ol (cholestanol) is a minor sterol found in animal tissues. It is structurally related to cholesterol but lacks the Δ5 double bond, resulting from reductive pathways of the Bloch/Kandutsch–Russell cholesterol biosynthesis routes or from hydrogenation of dietary cholesterol.
  • Membrane interactions: Like cholesterol, cholestanol intercalates into lipid bilayers. The absence of unsaturation slightly alters packing and ordering; cholestanol generally increases bilayer rigidity but can produce different phase behavior compared with cholesterol in model membranes (e.g., ternary raft-mimicking systems).
  • Transport and metabolism: Sterol transport proteins and lipoproteins can carry cholestanol similarly to cholesterol, though affinities and transfer rates may differ due to altered ring planarity and polarity.
  • Analytical marker: Measured in lipidomics and metabolomics to study sterol metabolism, dietary hydrogenation, or in quality control of sterol hydrogenation processes.
  • Protein interactions: Sterol-sensing domains and lipid-binding motifs may accommodate cholestanol with different binding energetics compared with cholesterol, useful for probing sterol–protein interactions in vitro.

Practical implications in research

  • Choice of sterol in membrane studies (cholesterol vs cholestanol) allows controlled evaluation of the role of ring unsaturation on lipid order, permeability, and protein function.
  • For reconstitution studies, solubilize alongside phospholipids in CHCl3:MeOH or ethanol and form thin films before hydration to achieve homogeneous incorporation.
Buffer Applications

This compound is not a buffer component and does not provide pH control. As a highly hydrophobic sterol, it is generally incompatible with purely aqueous buffers without co-solvents or surfactants.

Practical guidance

  • If incorporation into buffered systems is required (e.g., for liposome or proteoliposome preparation), dissolve the sterol with lipids in organic solvent, form a thin film, and then hydrate with the desired buffer (e.g., phosphate, HEPES). Alternatively, use cyclodextrins or detergent-mediated methods to transfer the sterol into aqueous media.
  • Maintain organic co-solvent content below levels that perturb biological assays, or remove via evaporation before buffer hydration.
Green Alternatives

Greener choices focus on solvent and reagent selection; the sterol itself is already fully saturated, reducing oxidative byproducts relative to cholesterol.

Solvent strategy (literature-guided)

  • Prefer ethanol or 2-propanol for dissolution and thin-film formation when feasible, in place of chlorinated solvents.
  • For acylations and routine workups, ethyl acetate and heptane/isohexane blends can replace DCM/hexane in many normal-phase chromatographies.
  • For oxidation to cholestan-3-one, consider “greener” oxidants (e.g., Oxone with catalytic TEMPO under biphasic conditions) over chromium(VI)-based reagents, where selectivity allows.

Small comparison (general; not item-specific specs)

  • DCM vs Ethyl acetate
    • DCM: Excellent solvency, low boiling point; environmental/health concerns.
    • Ethyl acetate: Safer profile, biodegradable; may require higher temperatures or longer times to dissolve sterols.
  • Pyridine vs DMAP/green bases
    • Pyridine: Volatile, odorous base/solvent; can be replaced by catalytic DMAP with greener solvents and tertiary amines (e.g., DIPEA) to reduce exposure.
  • Silylation
    • Traditional BSTFA in acetonitrile can be replaced with MSTFA in ethyl acetate or solvent-minimized microwave protocols, reducing chlorinated waste.

Operational tips

  • Use minimal solvent volumes with gentle heating (40–50 °C) and sonication to achieve dissolution.
  • Recover and recycle high-purity ethanol/IPA where infrastructure exists.
  • Implement solid-supported reagents (e.g., solid carbodiimides, resin-bound bases) to simplify workup and reduce aqueous waste.
Pharmaceutical Uses

Context (non-therapeutic; research/formulation only)

  • Excipient research: While cholesterol is the predominant sterol excipient in liposomes, lipid nanoparticles (LNPs), and other delivery systems, cholestanol is studied as a saturated sterol analog to tune membrane rigidity, leakage rates, and stability. Its absence of ring unsaturation can reduce oxidative degradation of formulations in stress studies (literature).
  • Reference and control material: Useful as a comparator to cholesterol in forced-degradation or stability-indicating methods evaluating sterol-containing dosage forms or lipid excipient quality.
  • Prototyping ester derivatives: Cholestanyl esters can be screened as hydrophobic excipients or as components of self-assembled systems in pre-formulation research.

Regulatory/status

  • Pharmacopeial monographs commonly exist for cholesterol; cholestanol may not have harmonized monographs. When considering use as an excipient in early-stage research, qualification should include identity (NMR/MS), purity, residual solvents, and peroxides/carbonyls where relevant.

Practical notes

  • Solubilize in pharmaceutically acceptable solvents (ethanol, isopropanol) for film formation; remove solvent thoroughly, then hydrate with buffered saline.
  • Avoid medical/clinical use: For research use only (per product data). Any progression toward clinical application requires full toxicological and quality assessments under appropriate regulatory frameworks.
Physical Properties

Item-specific specifications

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Literature and computed values (reference only; not item specifications)

  • Molecular formula/MW: C27H48O; 388.68 g/mol (literature)
  • Physical state: Waxy solid/needles (typical for sterols; literature)
  • Melting point: Typically 146–150 °C (literature range reported for cholestanol)
  • Boiling point: Not practical (decomposes before boiling at ambient pressure; literature)
  • Density: Approximately 1.0–1.1 g/cm3 (general range for sterols; literature)
  • LogP (octanol/water): Very high (sterol class often >8; literature, qualitative)
  • pKa: Alcohol O–H pKa ~16–18 in water (typical secondary alcohol; literature)
  • Solubility: Insoluble in water; soluble in organic solvents such as chloroform, dichloromethane, THF, hot ethanol/2-propanol, and to varying degrees in hexane/ethyl acetate (literature). Often dissolve by gentle warming and sonication.
  • UV-Vis: Lacks strong chromophores; minimal absorbance above 210–220 nm (literature), unlike cholesterol which shows weak Δ5-related absorbance.

Practical notes

  • For analytical sample prep, stock solutions in ethanol, isopropanol, or chloroform:methanol (2:1) are commonly used in lipid workflows. Warm to 40–50 °C if needed to fully dissolve.
  • Avoid attempting aqueous dissolution without a co-solvent or surfactant system.
Quality and Grades

Item-specific details

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretive guidance

  • For sterol standards and building blocks, typical research grades include:
    • Analytical/Reference grade: Tight control on purity and isomeric composition, suitable for quantitative analytical workflows (e.g., lipidomics). Low non-sterol impurities validated by NMR/GC-MS/HPLC.
    • Reagent grade: Suitable for synthesis and formulation development; may have broader impurity limits but often >95% purity.
    • Biochemical grade: Emphasis on trace peroxide and carbonyl content, and low residual solvents to protect sensitive biological assemblies.
  • Stabilizers: Sterols generally do not require added stabilizers; however, antioxidants (e.g., BHT) may occasionally be present in related unsaturated sterols. For 5α-cholestan-3β-ol (fully saturated), oxidative sensitivity is lower than cholesterol; verify any additives on the CoA.
  • Documentation to expect on CoA:
    • Identity: 1H/13C NMR consistent with 3β-OH stereochemistry, IR O–H stretch, and MS (m/z 388 [M]+ or [M+H]+).
    • Purity: HPLC/GC area percent; chiral/isomeric purity if relevant.
    • Residual solvent, water (KF), and heavy metal limits: Not specified for this item; refer to CoA/Spec Sheet.

Recommendation

  • Select grade based on end use: internal standard and quantitative work demand analytical grade; synthetic transformations may tolerate broader specs. Always verify lot-specific data on the CoA.
Reaction and Applications

Applications (research/manufacturing context)

  • Lipid/membrane studies: Cholestanol serves as a saturated sterol analog of cholesterol, used to probe membrane order, fluidity, and phase behavior owing to the absence of the Δ5 double bond (literature). It modulates bilayer rigidity differently than cholesterol.
  • Analytical internal standard: Employed in GC-MS/LC-MS lipidomics as an internal standard for sterol quantification, separation method development, or recovery tracking (literature).
  • Reference material: Used to benchmark derivatization protocols (e.g., silylation to TMS ethers) and chromatographic behaviors of sterols.

Synthetic/derivatization chemistry

  • Esterification: The 3β-OH undergoes acylation with acyl chlorides/anhydrides (often with pyridine or DMAP catalysis) to give cholestanyl esters for stability or membrane incorporation studies.
  • Tosylation/mesylation: Activation of the 3β-OH (TsCl or MsCl) allows further substitution or carbonate formation; careful control preserves stereochemistry.
  • Oxidation/reduction: PCC, PDC, or Dess–Martin oxidation affords cholestan-3-one; hydride reagents can reduce corresponding ketones. The saturated backbone is resistant to autoxidation relative to cholesterol.
  • Silylation: BSTFA or MSTFA furnishes TMS derivatives for GC analysis.

Practical tips

  • Drying: Although sterols are not highly hygroscopic, dry glassware/solvents improve yields in acylations and silylations.
  • Degassing: Not typically required unless working with oxygen-sensitive reagents; saturated sterol minimizes peroxide concerns.
  • Purification: Normal-phase silica gel with hexanes/ethyl acetate or hexanes/DCM gradients; monitor by anisaldehyde or sulfuric acid charring stain.
Reaction Conditions

General conditions (literature; guidance only)

  • Esterification (to cholestanyl esters):
    • Reagents: Acyl chloride (1.1–1.5 eq) or anhydride (2–3 eq), base (pyridine or DIPEA), catalytic DMAP (5–10 mol%).
    • Solvent: DCM, CHCl3, or toluene; 0–25 °C, 1–6 h. Workup with aqueous bicarbonate and brine. Typical yields: 80–95%.
  • Oxidation to cholestan-3-one:
    • PCC/DMP in DCM, 0–25 °C, 1–3 h; or TEMPO/Oxone (biphasic CH2Cl2/H2O with NaHCO3), 20–40 °C, several hours. Typical yields: 70–90%.
  • Tosylation of 3β-OH:
    • TsCl (1.2–1.5 eq), pyridine or Et3N, catalytic DMAP; DCM, 0 °C to RT, 2–6 h. Yields: 75–90%.
  • Silylation for GC derivatization:
    • BSTFA (or MSTFA) with 1% TMCS, 60–70 °C, 20–60 min in acetonitrile or ethyl acetate; quantitative conversion typically achieved.

Practical considerations

  • Solubility: Ensure complete dissolution (warm to 40–50 °C if needed) before adding reagents to avoid heterogeneous kinetics.
  • Stereochemistry: Reactions at C3 proceed with predictable retention/inversion depending on mechanism (e.g., SN1 vs SN2′ not operative; acylations retain configuration at carbon, alter only oxygen substituent).
  • Purification: Flash silica, hexanes/EtOAc 9:1 to 7:3; sterol esters elute later than alcohol.
  • Analytics: Monitor by TLC with anisaldehyde/H2SO4 stain or by GC after silylation. NMR (CDCl3) provides clear diagnostic shifts for 3β-O-acyl or 3-keto substitution.
Safety and Handling

Item-specific hazard information

  • Signal word: Not specified for this item; refer to SDS.
  • Hazard statements (H-phrases): Not specified for this item; refer to SDS.
  • GHS classification/pictograms: Not specified for this item; refer to SDS.

General safety guidance (consult SDS for authoritative data)

  • Expected hazards: Low acute toxicity profile typical of neutral sterols; may present as combustible organic solid and nuisance dust. Not classified as a strong irritant/corrosive under typical conditions, but handle as potentially harmful.
  • PPE: Laboratory coat, safety glasses or goggles, and appropriate disposable gloves (nitrile). Use dust mask/respirator if handling fine powders that may become airborne.
  • Engineering controls: Handle powders in a fume hood or ventilated enclosure to minimize inhalation and dust generation. Use anti-static practices when weighing.
  • Incompatibilities: Strong oxidizers may react with organic materials. Avoid chlorosulfonating reagents or strong dehydrating agents without appropriate controls.
  • First aid overview: If inhaled—move to fresh air. If on skin—wash with soap and water. If in eyes—rinse cautiously with water for several minutes. If ingested—rinse mouth; seek medical attention as needed. Always follow SDS guidance.
  • Spill/cleanup: Collect dry material with minimal dust generation; place in suitable container for disposal. Wash spill area with organic solvent compatible with waste procedures.
  • Fire safety: Use CO2, dry chemical, or foam. Combustion may produce CO/CO2; firefighters should wear self-contained breathing apparatus.
Solvent Selection

Solubility and polarity profile (general sterol behavior)

  • Polarity: Highly hydrophobic with a single secondary alcohol; behaves as a lipophilic amphiphile.
  • Water: Practically insoluble; requires co-solvents, surfactants, or inclusion systems for aqueous work.
  • Organic solvents: Good solubility in chloroform, dichloromethane, THF, dioxane, ethyl acetate (moderate), hot ethanol/2-propanol, and to varying extents in acetone and hexanes. Solubility often improves with gentle heating and sonication.
  • Lipid workflows: Common stock solvents include ethanol, isopropanol, or CHCl3:MeOH mixtures (2:1 or 3:1 v/v) for compatibility with lipid extraction and LC-MS sample handling.

When to choose which solvent

  • Formulation and lipid assembly: Ethanol or isopropanol for biophysical studies and liposome preps (easy removal, lower toxicity). Add a small percentage of water after dissolution to aid thin-film formation if needed.
  • Synthetic derivatization: DCM/CHCl3 for acylations, tosylations, and oxidations; pyridine or DMF as base/solvent for acylation or activation chemistry (with proper controls).
  • Analytical sample prep: CHCl3:MeOH facilitates co-dissolution with phospholipids and sterols; final dilution into IPA/ACN for LC-MS.

Comparison (literature-based; general)

  • Ethanol vs DCM: Ethanol is greener and safer but may require warming for full dissolution; DCM provides rapid dissolution at RT and is inert to many reagents but is less environmentally friendly.
  • Hexanes: Useful for chromatographic separations; limited solubility for bulk dissolution compared to chlorinated solvents.
Storage and Reconstitution

Item-specific conditions

  • Storage: Store at 2–8 °C (per Product Data). Keep container tightly closed.
  • Shipping: Shipped on wet ice (per Product Data).

General best practices

  • Protect from prolonged exposure to heat and light. Although fully saturated and less prone to autoxidation than cholesterol, store under inert atmosphere (nitrogen/argon) and with desiccant for long-term stability, especially for finely powdered material.
  • Container: Use amber glass vials with PTFE-lined caps to minimize permeation and adsorption.

Reconstitution guidance

  • Solvents: For immediate use, dissolve in ethanol, isopropanol, chloroform, dichloromethane, THF, or CHCl3:MeOH (2:1). Warm gently (40–50 °C) and sonicate to aid dissolution. Not water soluble; for aqueous systems use thin-film hydration, detergent-mediated incorporation, or cyclodextrin complexes.
  • Concentration/aliquoting: Prepare concentrated stocks (e.g., 10–50 mg/mL) and aliquot to minimize freeze–thaw and headspace. Store working solutions at 2–8 °C; for longer storage, keep at ≤−20 °C in sealed vials to limit solvent loss.

Stability notes

  • Inspect periodically for crystallization changes or contamination. Avoid repeated opening of cold containers to prevent moisture condensation.
  • If specifications (water content, residual solvents, peroxide value) are critical, consult the lot-specific CoA/Spec Sheet prior to use.

Research use only

  • As stated in Product Data: For research use only; not for human or veterinary use.
Structure and Identity

Item-specific (from Product Data)

  • Product name: 5α-cholestan-3β-ol (SKU: C130209)
  • CAS: 80-97-7
  • InChIKey: 309736 (as provided; note: format appears truncated—verify against CoA/SDS)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

Literature identity (for reference only; not item specifications)

  • Common name: Cholestanol; systematic: 5α-cholestan-3β-ol
  • Molecular formula: C27H48O (literature)
  • Molecular weight: 388.68 g/mol (literature)
  • PubChem CID: 6665 (literature)

Structural features (general chemistry)

  • Core scaffold: Tetracyclic steroid nucleus (cyclopentanoperhydrophenanthrene), fully saturated at C5 (5α) with trans-fused A/B rings typical of cholestane framework.
  • Functional groups: One secondary alcohol at C3 in the β-orientation (3β-OH); aliphatic iso-octyl side chain at C17; no π-bonds in the rings (distinguishes from cholesterol which has a Δ5 double bond).
  • Stereochemistry: Multiple defined stereocenters across the steroid backbone; 3β-hydroxyl is axial/equatorial depending on ring conformation but configuration is β (projecting above the plane of the A-ring). The 5α designation indicates the hydrogen at C5 is α, producing a trans A/B fusion.
  • 2D description in words: Four fused rings (three six-membered, one five-membered) bearing a single hydroxyl at C3 and a branched aliphatic side chain from C17; no ring unsaturation.

Notes

  • When precise identifiers (InChI, SMILES) are critical, consult the certificate of analysis (CoA) for this specific lot.
Synthetic Utility

Functional handles and reactivity (general chemistry)

  • 3β-Secondary alcohol: Amenable to acylation (Ac2O/DMAP, acyl chlorides), carbonate/carbamate formation, sulfonylation (TsCl/MsCl), and silylation (TMS, TBDMS). Stereoretentive transformations at C3 enable access to a library of cholestanyl derivatives.
  • Oxidation to ketone: PCC/DMP affords cholestan-3-one; subsequent stereoselective reductions (e.g., CBS, NaBH4 with chelation control) offer access to 3α/3β-epimers and deoxygenation routes.
  • Backbone: The robust, polycyclic sterane skeleton provides a chiral, rigid scaffold used in ligand design, organocatalyst supports, and materials where steric bulk and hydrophobicity are desired.

Retrosynthetic value

  • Protecting group strategies: The sole hydroxyl simplifies protection (e.g., silyl ether) while leaving the hydrophobic core intact for further side-chain manipulations.
  • Side-chain chemistry: Radical or ionic substitutions on the C17 side chain are less common but possible through activation (e.g., oxidation to aldehyde followed by homologation) after suitable functionalization.

Applications

  • Preparation of cholestanyl esters and carbonates for membrane studies.
  • Synthesis of labeled standards (e.g., deuterated cholestanol) for quantitative MS.
  • Benchmark substrate in comparing sterol derivatization protocols (silylation, acylation) and chromatographic selectivity on silica/NP-HPLC.
Target Specificity

Not applicable. This product is a small-molecule sterol, not a biological targeting reagent or antibody. No antigen/epitope, clone, isotype, or species reactivity information applies. For functional interaction studies (e.g., sterol–protein binding), refer instead to the Biological Roles and Reaction & Applications sections.

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.